AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.
RheumNow Live is unlike any meeting you’ve ever attended. Here’s why: You can attend RheumNow Live in person in Irving, Texas or the comfort of…
20,000 PC Business World magazine subscribers received this 5.25-inch floppy in the mail.
Because keeping the floors clean wasn’t impressive enough.
A patient in his late 60s with a prior history of widely metastatic prostatic adenocarcinoma was treated with androgen deprivation therapy and docetaxel chemotherapy. On…
Peripherally inserted central catheters (PICCs) are essential for providing vascular access for many patients. Original silicone catheters have been
We must resolve how thawing of permafrost as a result of climate change could resurface pathogens with the potential to infect humans, writes Kris A…
The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public companies.
One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui, emphasized its global ambitions and plans for more dealmaking at #JPM25.
High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its…
Learn how delicious, versatile corn can improve your gut health, lower cholesterol and protect your vision.